Dalfampridine IR is under clinical development by Solaxa and currently in Phase ...
AZD-2389 is under clinical development by AstraZeneca and currently in Phase I f...
NN-6561 is under clinical development by Novo Nordisk and currently in Phase I f...
CTX-310 is under clinical development by CRISPR Therapeutics and currently in Ph...
CTX-310 is under clinical development by CRISPR Therapeutics and currently in Ph...
CTX-310 is under clinical development by CRISPR Therapeutics and currently in Ph...
BNT-325 is under clinical development by Duality Biologics (Shanghai) and curren...
CAN-3110 is under clinical development by Candel Therapeutics and currently in P...
ICTCAR-028 is under clinical development by Innovative Cellular Therapeutics and...
LP-184 is under clinical development by Starlight Therapeutics and currently in ...
This study is reported by Zhangfa Song’s group from the Sir Run Run Shaw Hospita...
This study was led by Kezhong Chen (Department of Thoracic Surgery, Peking Unive...
His journey from a technical officer at ICI Petrochemicals to becoming the Regiu...
Products with sediment, such as soy milk, typically indicate on their packaging ...
A recent study by researchers from China, the UK and the Netherlands indicates h...
Limited impact of current movement restrictions highlights need for enhanced str...